How to measure the effects of the intracoronary stem cell therapy?

European Journal of Echocardiography

Volumn 11, Issue 5, 2010, Pages 438-439

  Tendera, Michał ^a   Wojakowski, Wojciech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN;

ANGIOCARDIOGRAPHY; BONE MARROW CELL; CELL TRANSFER; CLINICAL STUDY; DIASTOLE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION; SYSTOLE; THERAPY EFFECT; TISSUE DOPPLER IMAGING;

ANTIGENS, CD; ANTIGENS, CD34; BONE MARROW TRANSPLANTATION; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; GLYCOPROTEINS; HEART VENTRICLES; HUMANS; MYOCARDIAL ISCHEMIA; PEPTIDES; STEM CELL TRANSPLANTATION; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 77953855510     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jeq025     Document Type: Review

References (12)

1. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007;50:1761-1767
2. Schachinger V, Erbs S, Elsasser A, HaberboschW, Hambrecht R, Holschermann H et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221 (Pubitemid 44427445)
3. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C et al. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 2004;364: 141-148
4. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months follow-up data from the randomized, controlled BOOST trial. Circulation 2006;113: 1287-1296
5. Meyer GP, Wollert KC, Lotz J, Pirr J, Rager U, Lippolt P et al. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the ramdomized-controlled BOOST trial. Eur Heart J 2009;30:2978-2984
6. Ischii K, Suyama T, Imai M, Maenaka M, Yamanaka A, Makino Y et al. Abnormal regional left ventricular systolic and diastolic function in patients with coronary artery disease undergoing percutaneous coronary intervention. J Am Coll Cardiol 2009;54:1589-1597
7. Husic M, Norager B, Egstrup K, Lang RM, Moller JE. Diastolic wall motion abnormality after myocardial infarction: relation to neurohormonal activation and prognostic implications. Am Heart J 2005;150:767-774 (Pubitemid 41396513)
8. Carluccio E, Biagioli P, Alunni G, Murrone A, Leonelli V, Pantano P et al. Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy. Eur Heart J 2009;30:1501-1509
9. Schaefer A, Meyer GP, Fuchs M, Klein G, Kaplan M, Wollert KC et al. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial. Eur Heart J 2006;27: 929-935
10. Schaefer A, Zwadlo C, Fuchs M, Meyer GP, Lippolt P,Wollert KC et al. Long-term effects of intracoronary bone morrow cell transfer on diastolic function in patients after acute myocardial infarction: 5-year results from the randomised, controlled BOOST trial-an echocardiographic study. Eur J Echocardiogr 2010; 11:165-171
11. Karatasakis G, Leontiadis E, Peristeri I, Manginas A, Goussetis E, Graphakos S et al. Intracoronary infusion of selected autologous bone marrow stem cells improves longitudinal myocardial strain and strain rate in patients with old anterior myocardial infarction without recent revascularization. Eur J Echocardiogr 2010; 11:440-445
12. WojakowskiW, Tendera M, Kucia M, Zuba-Surma E, Paczkowska E, Ciosek J et al. Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryoniclike stem cells in patients with acute myocardial infarction. J Am Coll Cardiol 2009;53:1-9.